# 21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/21-gene-recurrence-score-decreases-receipt-of-chemotherapy-in-er-early-stage/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Benjamin M. Parsons,Jeffrey Landercasper,Angela Smith,Ronald S. Go,Andrew J. Borgert,Leah L. Dietrich |
| Citations | 18 |
| DOI | 10.1007/s10549-016-3926-5 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s10549-016-3926-5.pdf |
| OpenAlex ID | https://openalex.org/W2511324858 |
| PMID | 27507245 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Leah L. Dietrich](https://scholariq.org/researchers/leah-l-dietrich/)

## Paper journal

- [Breast Cancer Research and Treatment](https://scholariq.org/journals/breast-cancer-research-and-treatment/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.